Neurologic Presentations of Systemic Vasculitides

Neurologic Clinics

Volumn 28, Issue 1, 2010, Pages 171-184

  Minagar, Alireza ^a   Fowler, Marjorie ^a   Harris, Meghan K ^a   Jaffe, Stephen L ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Arteritis; Cryoglobulinemia; Purpura; Vasculitis

Indexed keywords

ALENDRONIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; CHLORAMBUCIL; CHLORMETHINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN DERIVATIVE; PREDNISONE; RITUXIMAB;

ANAPHYLACTOID PURPURA; AORTA ARCH SYNDROME; AORTOGRAPHY; ARTERY BYPASS; BRAIN VASCULITIS; CLINICAL FEATURE; CORTICOSTEROID INDUCED OSTEOPOROSIS; CRANIAL NEUROPATHY; CRYOGLOBULINEMIA; DIAGNOSTIC VALUE; DRUG ABUSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG RESPONSE; HUMAN; MICROSCOPIC POLYANGIITIS; NEUROLOGIC DISEASE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; REVIEW; STROKE; SYSTEMIC VASCULITIS; TEMPORAL ARTERITIS; TRANSIENT ISCHEMIC ATTACK; UNSPECIFIED SIDE EFFECT; VASCULAR NECROSIS; VASCULITIS; WEGENER GRANULOMATOSIS;

ARTERIES; BRAIN; HUMANS; NERVOUS SYSTEM DISEASES; SYSTEMIC VASCULITIS;

EID: 70449625760     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2009.09.015     Document Type: Review

References (31)

1. Jayne D. Treatment of ANCA-associated systemic small-vessel vasculitis. APMIS Suppl 127 (2009) 3-9
2. Holle J.U., and Gross W.L. ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapy. J Autoimmun 32 3-4 (2009) 163-171
3. Pankhurst T., Savage C.O., and Little M.A. Review article: leukocyte-endothelial dysregulation in systemic small vessel vasculitis. Nephrology (Carlton) 14 1 (2009) 3-10
4. Ojeda V.J. Polyarteritis nodosa affecting the spinal cord arteries. Aust N Z J Med 13 (1983) 287-289
5. Watts R.A., Carruthers D.M., and Scott D.G. Epidemiology of systemic vasculitis: changing incidence or definition?. Semin Arthritis Rheum 25 1 (1995) 28-34
6. Hunder G.G. Epidemiology of giant-cell arteritis. Cleve Clin J Med 69 Suppl 2 (2002) SII79-SII82
7. Baldursson O., Steinsson K., Björnsson J., et al. Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum 37 7 (1994) 1007-1012
8. Nordborg C., Nordborg E., and Petursdottir V. Giant cell arteritis. Epidemiology, etiology and pathogenesis. APMIS 108 11 (2000) 713-724
9. Ostberg G. Temporal arteritis in a large necropsy series. Ann Rheum Dis 30 3 (1971) 224-235
10. Weyand C.M., and Goronzy J.J. Medium- and large-vessel vasculitis. N Engl J Med 349 2 (2003) 160-169
11. Caselli R.J., Hunder G.G., and Whisnant J.P. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 38 3 (1988) 352-359
12. Koorey D.J. Cranial arteritis. A twenty-year review of cases. Aust N Z J Med 14 2 (1984) 143-147
13. Eberhardt R.T., and Dhadly M. Giant cell arteritis: diagnosis, management, and cardiovascular implications. Cardiol Rev 15 2 (2007) 55-61
14. Nadeau S.E. Neurologic manifestations of systemic vasculitis. Neurol Clin 20 1 (2002) 123-150
15. Cantini F., Niccoli L., Storri L., et al. Are polymyalgia rheumatica and giant cell arteritis the same disease?. Semin Arthritis Rheum 33 5 (2004) 294-301
16. Epperly T.D., Moore K.E., and Harrover J.D. Polymyalgia rheumatica and temporal arthritis. Am Fam Physician 62 4 (2000) 789-796 801
17. Hunder G.G., Bloch D.A., Michel B.A., et al. The American College of rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33 8 (1990) 1122-1128
18. Arend W.P., Michel B.A., Bloch D.A., et al. The American College of rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33 8 (1990) 1129-1134
19. Provenzale J.M., and Allen N.B. Wegener granulomatosis: CT and MR findings. AJNR Am J Neuroradiol 17 (1996) 785-792
20. de Groot K., Reinhold-Keller E., Tatsis E., et al. Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum 39 (1996) 2052-2061
21. Abramsky O., and Slavin S. Neurologic manifestations in patients with mixed cryoglobulinemia. Neurology 24 3 (1974) 245-249
22. Petty G.W., Duffy J., and Houston III J. Cerebral ischemia in patients with hepatitis C virus infection and mixed cryoglobulinemia. Mayo Clin Proc 71 7 (1996) 671-678
23. Reik Jr. L., and Korn J.H. Cryoglobulinemia with encephalopathy: successful treatment by plasma exchange. Ann Neurol 10 5 (1981) 488-490
24. Ristow S.C., Griner P.F., Abraham G.N., et al. Reversal of systemic manifestations of cryoglobulinemia. Treatment with melphalan and prednisone. Arch Intern Med 136 4 (1976) 467-470
25. Mills J.A., Michel B.A., Bloch D.A., et al. The American College of rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 33 8 (1990) 1114-1121
26. Bartzokis G., Beckson M., Hance D.B., et al. Magnetic resonance imaging evidence of "silent" cerebrovascular toxicity in cocaine dependence. Biol Psychiatry 45 9 (1999) 1203-1211
27. Lhote F., and Guillevin L. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects and treatment. Rheum Dis Clin North Am 21 (1995) 911-947
28. Kurland L.T., Hauser W.A., Ferguson R.H., et al. Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn., 1951 through 1967, with special reference to systemic lupus erythematosus. Mayo Clin Proc 44 9 (1969) 649-663
29. Lightfoot Jr. R.W., Michel B.A., Bloch D.A., et al. The American College of rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33 8 (1990) 1088-1093
30. Provenzale J.M., and Allen N.B. Neuroradiologic findings in polyarteritis nodosa. AJNR Am J Neuroradiol 17 6 (1996) 1119-1126
31. Savage C.O., Winearls C.G., Evans D.J., et al. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 56 220 (1985) 467-483